Articles from Antidepressants

Primary tabs

Health Highlights: Feb. 14, 2019 - HealthDay

Submitted by Anonymous (not verified) on Thu, 02/14/2019 - 13:41

Health Highlights: Feb. 14, 2019  HealthDayHere are some of the latest health and medical news developments, compiled by the editors of HealthDay: FDA Panel Backs Ketamine-like Drug for Depression.

Health Highlights: Feb. 14, 2019 | Health News - U.S. News & World Report

Submitted by Anonymous (not verified) on Thu, 02/14/2019 - 13:39

Health Highlights: Feb. 14, 2019 | Health News  U.S. News & World ReportFDA Panel Backs Ketamine-like Drug for Depression.

FDA could soon approve a nasal spray to treat depression - WSLS 10

Submitted by Anonymous (not verified) on Thu, 02/14/2019 - 13:19

FDA could soon approve a nasal spray to treat depression  WSLS 10The FDA is on the brink of approving a breakthrough depression drug. Johnson & Johnson's esketamine is a fast-acting antidepressant administered by a nasal ...

Second chances: 7 Central Illinois death cases that were overturned - Bloomington Pantagraph

Submitted by Anonymous (not verified) on Thu, 02/14/2019 - 13:00

Second chances: 7 Central Illinois death cases that were overturned  Bloomington PantagraphDonald Whalen is not the only Central Illinoisan to have won a retrial in a death case. These other defendants also had their cases overturned by a higher court.

GPs should refer more elderly depression patients for non-drug treatments - Pulse

Submitted by Anonymous (not verified) on Thu, 02/14/2019 - 12:41

GPs should refer more elderly depression patients for non-drug treatments  PulseOlder adults diagnosed with depression could benefit from non-drug treatment such as psychological therapies from their primary care providers, according to a ...

FDA to Review Pitolisant for Narcolepsy Treatment - Monthly Prescribing Reference

Submitted by Anonymous (not verified) on Thu, 02/14/2019 - 12:24

FDA to Review Pitolisant for Narcolepsy Treatment  Monthly Prescribing ReferenceHarmony Biosciences announced that the Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for pitolisant ...

Antidepressant drug could save people from deadly sepsis, research suggests - News-Medical.net

Submitted by Anonymous (not verified) on Thu, 02/14/2019 - 10:18

Antidepressant drug could save people from deadly sepsis, research suggests  News-Medical.netAn antidepressant drug used to treat obsessive-compulsive disorder could save people from deadly sepsis, new research from the University of Virginia School ...

Trazodone Not Associated With Reduced Risk for Dementia - Psychiatry Advisor

Submitted by Anonymous (not verified) on Thu, 02/14/2019 - 10:00

Trazodone Not Associated With Reduced Risk for Dementia  Psychiatry AdvisorTrazodone is not associated with a reduced risk for dementia compared with other antidepressants at the prodromal stage of disease.

FDA panel backs ketamine-like drug for depression - Medical Xpress

Submitted by Anonymous (not verified) on Thu, 02/14/2019 - 08:00

FDA panel backs ketamine-like drug for depression  Medical Xpress(HealthDay)—An expert panel for the U.S. Food and Drug Administration has endorsed a drug for major depressive disorder that is a close relative to ketamine.

CDC: Flu shot much more effective this year - UPI News

Submitted by Anonymous (not verified) on Thu, 02/14/2019 - 08:00

CDC: Flu shot much more effective this year  UPI NewsThis year's flu shot is already outperforming the vaccine issued during the tough 2017-2018 influenza season, federal health officials reported Thursday.

Pages